VBIO

Value 2022202320242025 TTM Total revenue 1.84 M1.18 M780 K28 K — Gross profit 299 K287 K2 00028 K — Operating expenses 10.4 M8.53 M5.66 M7.9 M 12.15 M Selling/general/admin expenses 8.67 M6.88 M4.35 M4.77 M 6.74 M Research & development 1.73 M1.66 M1.31 M3.13 M 4.65 M Operating income -10.1 M-8.24 M-5.66 M-7.9 M -12.15 M Non-Operating Income, Total 2 0001 0006 000-95 K -690 K Interest expense, net of interest capitalized ———146 K — Non-Operating Income, excl. Interest Expenses 2 0001 0006 000-241 K -1.34 M Unusual income/expense ———— — Pretax income -10.1 M-8.24 M-5.66 M8.9 M -2.5 M Equity in earnings ———— — Taxes -2.9 M-354 K-9000 — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -10.1 M-8.24 M-5.66 M-7.99 M -13.6 M Discontinued operations ———-885 K — Net income -10.1 M-8.24 M-5.66 M-8.88 M -13.58 M Dilution adjustment ———0 — Preferred dividends ———168 K — Diluted net income available to common stockholders -10.1 M-8.24 M-5.66 M-9.05 M -13.85 M Basic earnings per share (Basic EPS) -1 768-176.8-19.68-7.84 -7.55 Diluted earnings per share (Diluted EPS) -1 768-176.8-19.68-7.68 -8.77 Average basic shares outstanding 5 689.9746.65 K287.37 K1.16 M — Diluted shares outstanding 5 689.9746.65 K287.37 K1.16 M — EBITDA -10.09 M-8.24 M-5.66 M-7.77 M — EBIT -10.1 M-8.24 M-5.66 M-7.87 M — Cost of revenue 1.54 M889 K778 K— — Other cost of goods sold —32 K354 K— — Depreciation & amortization (cash flow) 10 K8 0003 000102 K 453 K